Cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011.
AbstractBackground: Cutaneous leishmaniasis (CL) is a major health problem in many parts of Iran, although diagnosis of CL especially in the endemic area is easy, but treatment and management of the disease is a global dilemma. Diag-nosis of CL in non-endemic area is not as simple as in endemic foci. In this study, the status and the proportions of CL induced by Leishmania major and L. tropica among CL suspected patients referred to the Center for Research and Training in Skin Diseases and Leprosy, (CRTSDL) during 2008 to 2011 are described. Methods: CL patients with suspected lesions were clinically examined. History of trip to zoonotic CL and/or anthroponotic CL endemic areas and the char-acteristics of their lesion(s) were recorded. Diagnosis of the lesion was done using direct smear microscopy, culture and conventional polymerase chain reaction (PCR). Results: A total of 404 (M=256, F=148) patients with 776 lesions were re-cruited and parasitologically examined. The results showed that 255 of the pa-tients with 613 lesions; patients with lesion(s) induced by L. major=147 (M=63, 43%, F=84, 57%) and lesion(s) induced by L. tropica=108 (M=35, 32%, F=73, 68%). History of travel to endemic area was not always correlated with isolated Leishmania species. Conclusion: Although travel history to endemic area is an important factor to be considered for diagnosis, but parasitological confirmation is necessary initia-tion of treatment.
WHO Technical Report Series (2010). Con-trol of the Leishmaniasis, 949, pp1-201.
Alvar J, Velez DI, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M. The WHO Leishmaniasis Control Team. Leishmaniasis worldwide and global esti-mates of its incidence. PLOS One. 2012; 7(5) e35671.
Asilian A, Khamesipour A, Modabber F. Leishmaniasis. Postgraduate Doctor. 1998; 2:174-181.
Noazin S, Khamesipour A, Moulton L, Tan-ner M, Nasseri K, Modabber F, Sharifi I, Khalil EAG, Velez Bernal ID, Antunes CMF, Smith PG. Efficacy of killed whole-parasite vaccines in the prevention of Leishmaniasis-A meta-analysis. Vaccine. 2009; 27: 4747-53.
Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil Eltahir AG, Velez Bernal ID, Antunes Carlos MF, Kieny MP, Tanner M. First gen-eration leishmaniasis vaccines: A review of field efficacy trials. Vaccine. 2008; 26:6759-67.
Vaccines for the Leishmaniasis: Proposals for a Research Agenda, Questions and Issues Raised During the International Symposium on Leishmaniasis Vaccines. Olinda, Brazil, March 9-11, 2009. PLoS Neglected Tropical Dis. 2011, Volume 5, Issue 3, e943.
Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar A, Steven Reed SG. Case study for vaccine against leishmaniasis. Decade of vac-cines. Vaccine Supplement. (13)2, 2013, B244-B249.
Statistics of cutaneous leishmaniasis in Iran: Hearing before National Leishmaniasis Com-mittee, Office of Zoonoses, Center of Dis-ease Control, Ministry of Health and Medical Education, (Sep. 30, 2004).
Dowlati Y. Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol. 1996; 14:513-7.
Khatami A, Firooz A, Gorouhi F, Dowlati Y. Treatment of acute Old World cutaneous leish-maniasis: A systematic review of the rando-mized controlled trials. J Am Acad Dermaol. 2007; 57: 335. e1-29.
Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unrespon-siveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug resistant Leishmania tropica parasites. PLoS Med. 2006;3:e162.
Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (Twice/Day) with intralesional meglumine antimonate for the treatment of cutaneous leishmaniasis caused by L. major. Eur J Dermatol. 2005; 15:1-3.
Nassiri Kashani M, Firooz A, Eskandari SE, Ghoorchi MH, Khamesipour A, Khatami A, Javadi A, Dowlati Y. Evaluation of meglumine antimoniate effects on liver, kidney and pan-creas function tests in patients with cutaneous Leishmaniasis. Eur J Dermatol. 2007; 17: 513-515.
Vega Lonez F. Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis. 2003; 16:97-101.
Akhavan AA, Mirhendi H, Khamesipour A et al. Leishmania species: Detection and identifica-tion by nested PCR assay from skin samples of rodent reservoirs. Exp Parasit. 126 (2010) 552–556.
Postigo RJ A. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Inter J Antimicrobial Agents. 2010; 36: 62-65.
Sharifi I, Fekri AR, Aflatoonian MR, Nadim A, Nikian Y, Khamesipour A. Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994–95. Bull of the WHO. 1998a; 76, 289–293.
Sharifi I, Poursmaelian S, Aflatoonian MR, Fotouhi Ardakani R, Mirzaei M, Fekri AR, Khamesipour A, Hakimi Parizi M, Fasihi Ha-randi M. Emergence of a new focus of Anthroponotic Cutaneous Leishmaniasis due
to Leishmania tropica in rural communities of Bam district after the earthquake, Iran. Trop Med Inter Health. 2011; 4: 510–513.
Sharifi I, Nakhaei N, Aflatoonian MR, Hakimi Parizi M, Fekri AR, Safizadeh H, Shirzadi MR, Gooya MM, Khamesipour A, Nadim A. Cuta-neous leishmaniasis in Bam: A comparative evaluation of pre- and post-earthquake years (1999-2008). Iranian J Publ Health. 2011; 40: 49-56.
Fata A, Khamesipour A, Mohajery M, Hosseininejad Z, Afzalaghaei M, Berenji F, Ganjbakhsh M, Akhavan AA, Eskandari SE, Amin-mohammadi A. Whatman paper (FTA cards) for storing and transferring Leishmania DNA for PCR examination. Iranian J Parasitol. 2009 (4):37-42.
Sharifi F, Sharifi I, Zarean M, Hakimi Parizi M, Aflatoonian MR, Fasihi Harandi M, Zah-matkesh R., Mashayekhi M, Kermanizadeh AR. Spatial Distribution and Molecular Identifica-tion of Leishmania Species from Endemic Foci of South-Eastern Iran. Iranian J Parasitol. 2012; 7:45-52.